Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data
Bio Expo
Champignondagen
  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • News

New Guideline Expands Access to Advanced Liver Ultrasound, Experts Say

  • The Pharma Data
  • July 15, 2025

New Guidelines Expand Access to Advanced Liver Imaging and Transplant Evaluations Using Contrast-Enhanced Ultrasound A new policy change is being hailed by medical experts as a transformative advancement in the…

Read MoreNew Guideline Expands Access to Advanced Liver Ultrasound, Experts Say
  • Press Releases

HistoSonics Secures Coverage for Liver Tumor Therapy in 7M Highmark Members

  • The Pharma Data
  • July 15, 2025

HistoSonics Expands Access to Groundbreaking Non-Invasive Liver Tumor Treatment as Highmark Covers Histotripsy for 7 Million Members In a pivotal development for patients battling liver tumors, HistoSonics, the medical technology…

Read MoreHistoSonics Secures Coverage for Liver Tumor Therapy in 7M Highmark Members
  • Research

Acadia Unveils New Team and Pipeline, Eyes Biotech Powerhouse Status

  • The Pharma Data
  • July 15, 2025

Acadia Pharmaceuticals Unveils Ambitious Growth Strategy, Eyes $12 Billion Pipeline with Female-Led R&D Powerhouse More than three decades after its founding in 1993, Acadia Pharmaceuticals is embracing a bold new…

Read MoreAcadia Unveils New Team and Pipeline, Eyes Biotech Powerhouse Status
  • Research

Takeda Reports Positive Phase 3 Results for Oveporexton in Narcolepsy Type 1

  • The Pharma Data
  • July 15, 2025

Takeda’s Oveporexton Achieves Landmark Phase 3 Success in Narcolepsy Type 1, Paving Way for First-in-Class Orexin Therapy Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) has announced a major milestone in its development…

Read MoreTakeda Reports Positive Phase 3 Results for Oveporexton in Narcolepsy Type 1
  • Press Releases

ViiV Expands MPP Deal for Long-Acting HIV Treatment Access

  • The Pharma Data
  • July 15, 2025

ViiV Healthcare Broadens Voluntary Licensing Deal with MPP to Include Long-Acting Injectable HIV Treatment in Global Access Push GSK plc (LSE/NYSE: GSK) announced that its majority-owned subsidiary, ViiV Healthcare—a global…

Read MoreViiV Expands MPP Deal for Long-Acting HIV Treatment Access
  • News

Baxdrostat Meets All Endpoints in Phase III Hypertension Trial

  • The Pharma Data
  • July 15, 2025

Baxdrostat Achieves Positive Results in Phase III BaxHTN Trial, Demonstrating Significant Blood Pressure Reduction in Patients with Uncontrolled or Resistant Hypertension AstraZeneca has announced promising top-line results from its pivotal…

Read MoreBaxdrostat Meets All Endpoints in Phase III Hypertension Trial
  • News

WHO Sets Up Collaborative Networks for Pathogen Genomics Surveillance

  • The Pharma Data
  • July 12, 2025

WHO’s International Pathogen Surveillance Network Launches Communities of Practice to Advance Genomic Surveillance The World Health Organization’s (WHO) Hub for Pandemic and Epidemic Intelligence has taken a major step forward…

Read MoreWHO Sets Up Collaborative Networks for Pathogen Genomics Surveillance
  • News

Burundi Declared Free of Health as a Public Health Threat

  • The Pharma Data
  • July 12, 2025

Burundi Eliminates Trachoma as a Public Health Problem, Marking Major Milestone in Disease Control The World Health Organization (WHO) has officially validated that Burundi has eliminated trachoma as a public…

Read MoreBurundi Declared Free of Health as a Public Health Threat
  • News

Webinar Highlights Public Procurement’s Role in Tackling Health Issues

  • The Pharma Data
  • July 12, 2025

WHO-WIPO-WTO Webinar Highlights Role of Public Procurement in Advancing Global Health Equity and Innovation On July 3, 2025, the World Health Organization (WHO), the World Intellectual Property Organization (WIPO), and…

Read MoreWebinar Highlights Public Procurement’s Role in Tackling Health Issues
  • Press Releases

Walgreens Boots Alliance Shareholders Greenlight Sycamore Partners Deal

  • The Pharma Data
  • July 12, 2025

Walgreens Boots Alliance Shareholders Overwhelmingly Approve Acquisition by Sycamore Partners Walgreens Boots Alliance, announced a significant milestone on the path to its planned acquisition by Sycamore Partners Management, L.P. Shareholders…

Read MoreWalgreens Boots Alliance Shareholders Greenlight Sycamore Partners Deal
  • News

Capricor Shares Drop After FDA Rejects DMD Cell Therapy Application

  • The Pharma Data
  • July 12, 2025

Capricor Shares Tumble After FDA Rejects Cell Therapy for Duchenne Cardiomyopathy Over Efficacy Concerns Capricor Therapeutics suffered a major regulatory setback Friday after the U.S. Food and Drug Administration (FDA)…

Read MoreCapricor Shares Drop After FDA Rejects DMD Cell Therapy Application
  • Regulatory

Moderna Receives Full Approval for COVID-19 Vaccine in High-Risk Children

  • The Pharma Data
  • July 12, 2025

Moderna Secures Full FDA Approval for Spikevax in High-Risk Children Amid Growing mRNA Scrutiny Moderna has scored another key regulatory milestone as the U.S. Food and Drug Administration (FDA) granted…

Read MoreModerna Receives Full Approval for COVID-19 Vaccine in High-Risk Children
PrevNext
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • ClearNote Health Launches Enhanced Avantect® Pancreatic Cancer Test
  • Gossamer Bio Announces Topline Results for Phase 3 PROSERA Study of Seralutinib in PAH
  • Synthekine Inc. Appoints John A. Orwin as Board Chair to Lead Clinical Expansion
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.